Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 872983, 17 pages
http://dx.doi.org/10.1155/2015/872983
Research Article

Peripheral Blood Mononuclear Cell Proteome Changes in Patients with Myelodysplastic Syndrome

Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic

Received 23 September 2014; Accepted 31 March 2015

Academic Editor: Shivani Soni

Copyright © 2015 Klara Pecankova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Schecter, N. Galili, and A. Raza, “MDS: refining existing therapy through improved biologic insights,” Blood Reviews, vol. 26, no. 2, pp. 73–80, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Neuwirtová, “Myelodysplastický syndrom: onkohematologické onemocnění vyššího věku,” Česká Geriatrická Revue, vol. 3, no. 2, pp. 21–28, 2005. View at Google Scholar
  3. J. W. Vardiman, J. Thiele, D. A. Arber et al., “The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes,” Blood, vol. 114, no. 5, pp. 937–951, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Májek, Z. Riedelová-Reicheltová, J. Suttnar, K. Pečánková, J. Čermák, and J. E. Dyr, “Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome,” Proteome Science, vol. 11, no. 1, article 14, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Májek, Z. Reicheltová, J. Suttnar, J. Čermák, and J. E. Dyr, “Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia,” Proteome Science, vol. 9, article 64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Májek, Z. Reicheltová, J. Suttnar, J. Čermák, and J. E. Dyr, “Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelodysplastic syndrome,” Proteome Science, vol. 10, no. 1, article 31, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Májek, Z. Riedelová-Reicheltová, J. Suttnar, K. Pecankova, J. Čermák, and J. E. Dyr, “Proteome changes in the plasma of myelodysplastic syndrome patients with refractory anemia with excess blasts subtype 2,” Disease Markers, vol. 2014, Article ID 178709, 8 pages, 2014. View at Publisher · View at Google Scholar
  8. M. Aivado, D. Spentzos, U. Germing et al., “Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 4, pp. 1307–1312, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Chen, D. T. Bowen, A. A. N. Giagounidis, B. Schlegelberger, S. Haase, and E. G. Wright, “Identification of disease- and therapy-associated proteome changes in the sera of patients with myelodysplastic syndromes and del(5q),” Leukemia, vol. 24, no. 11, pp. 1875–1884, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Fröbel, R.-P. Cadeddu, S. Hartwig et al., “Platelet proteome analysis reveals integrin-dependent aggregation defects in patients with myelodysplastic syndromes,” Molecular & Cellular Proteomics, vol. 12, no. 5, pp. 1272–1280, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Kazama, M. Teramura, S. Kurihara, K. Yoshinaga, T. Kato, and T. Motoji, “Peroxiredoxin 2 expression is increased in neutrophils of patients with refractory cytopenia with multilineage dysplasia,” British Journal of Haematology, vol. 166, no. 5, pp. 720–728, 2014. View at Google Scholar
  12. P. L. Greenberg, Ed., Myelodysplastic Syndromes: Clinical and Biological Advances, Cambridge University Press, Cambridge, UK, 2006.
  13. M. J. Walter, D. Shen, J. Shao et al., “Clonal diversity of recurrently mutated genes in myelodysplastic syndromes,” Leukemia, vol. 27, no. 6, pp. 1275–1282, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Bains, R. Luthra, L. J. Medeiros, and Z. Zuo, “FLT3 and NPM1 mutations in myelodysplastic syndromes: frequency and potential value for predicting progression to acute myeloid leukemia,” The American Journal of Clinical Pathology, vol. 135, no. 1, pp. 62–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. C.-Y. Chen, L.-I. Lin, J.-L. Tang et al., “RUNX1 gene mutation in primary myelodysplastic syndrome—the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome,” British Journal of Haematology, vol. 139, no. 3, pp. 405–414, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J.-P. Issa, “Epigenetic changes in the myelodysplastic syndrome,” Hematology/Oncology Clinics of North America, vol. 24, no. 2, pp. 317–330, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Sugimori, A. F. List, and P. K. Epling-Burnette, “Immune dysregulation in myelodysplastic syndrome,” Hematology Reports, vol. 2, no. 1, article e1, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Vergara, F. Chiriacò, R. Acierno, and M. Maffia, “Proteomic map of peripheral blood mononuclear cells,” Proteomics, vol. 8, no. 10, pp. 2045–2051, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Maccarrone, C. Rewerts, M. Lebar, C. W. Turck, and D. Martins-de-Souza, “Proteome profiling of peripheral mononuclear cells from human blood,” Proteomics, vol. 13, no. 5, pp. 893–897, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Maes, B. Landuyt, I. Mertens, and L. Schoofs, “Interindividual variation in the proteome of human peripheral blood mononuclear cells,” PLoS ONE, vol. 8, no. 4, Article ID e61933, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. J. W. Vardiman, N. L. Harris, and R. D. Brunning, “The World Health Organization (WHO) classification of the myeloid neoplasms,” Blood, vol. 100, no. 7, pp. 2292–2302, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Májek, Z. Reicheltová, J. Štikarová, J. Suttnar, A. Sobotková, and J. E. Dyr, “Proteome changes in platelets activated by arachidonic acid, collagen, and thrombin,” Proteome Science, vol. 8, article 56, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Májek, Z. Riedelová-Reicheltová, K. Pecánková, and J. E. Dyr, “Improved coomassie blue dye-based fast staining protocol for proteins separated by SDS-PAGE,” PLoS ONE, vol. 8, no. 11, Article ID e81696, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Glaab, A. Baudot, N. Krasnogor, R. Schneider, and A. Valencia, “EnrichNet: network-based gene set enrichment analysis,” Bioinformatics, vol. 28, no. 18, pp. i451–i457, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Kanehisa, S. Goto, Y. Sato, M. Kawashima, M. Furumichi, and M. Tanabe, “Data, information, knowledge and principle: back to metabolism in KEGG,” Nucleic Acids Research, vol. 42, no. 1, pp. D199–D205, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Kanehisa and S. Goto, “KEGG: kyoto encyclopedia of genes and genomes,” Nucleic Acids Research, vol. 28, no. 1, pp. 27–30, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Croft, A. F. Mundo, R. Haw et al., “The reactome pathway knowledgebase,” Nucleic Acids Research, vol. 42, no. 1, pp. D472–D477, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. M. M. Milacic, R. Haw, K. Rothfels et al., “Annotating cancer variants and anti-cancer therapeutics in reactome,” Cancers, vol. 4, no. 4, pp. 1180–1211, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. K. E. Sullivan, J. Cutilli, L. M. Piliero et al., “Measurement of cytokine secretion, intracellular protein expression, and mRNA in resting and stimulated peripheral blood mononuclear cells,” Clinical and Diagnostic Laboratory Immunology, vol. 7, no. 6, pp. 920–924, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. D. G. Haider, N. Leuchten, G. Schaller et al., “C-reactive protein is expressed and secreted by peripheral blood mononuclear cells,” Clinical and Experimental Immunology, vol. 146, no. 3, pp. 533–539, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. K. A. Browne, R. W. Johnstone, D. A. Jans, and J. A. Trapani, “Filamin (280-kDa actin-binding protein) is a caspase substrate and is also cleaved directly by the cytotoxic T lymphocyte protease granzyme B during apoptosis,” The Journal of Biological Chemistry, vol. 275, no. 50, pp. 39262–39266, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Bennett, Understanding Myelodysplastic Syndromes: A Patient Handbook, The Myelodysplastic Syndromes Foundation, Crosswicks, NJ, USA, 6th edition, 2008.
  33. C. Coghlin, B. Carpenter, S. R. Dundas, L. C. Lawrie, C. Telfer, and G. I. Murray, “Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer,” The Journal of Pathology, vol. 210, no. 3, pp. 351–357, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. M. B. Yaffe, G. W. Farr, D. Miklos, A. L. Horwich, M. L. Sternlicht, and H. Sternlicht, “TCP1 complex is a molecular chaperone in tubulin biogenesis,” Nature, vol. 358, no. 6383, pp. 245–248, 1992. View at Publisher · View at Google Scholar · View at Scopus
  35. S. C. Goetz and K. V. Anderson, “The primary cilium: a signalling centre during vertebrate development,” Nature Reviews Genetics, vol. 11, no. 5, pp. 331–344, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Finetti, S. R. Paccani, M. G. Riparbelli et al., “Intraflagellar transport is required for polarized recycling of the TCR/ CD3 complex to the immune synapse,” Nature Cell Biology, vol. 11, no. 11, pp. 1332–1339, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. I. B. Alieva and I. A. Vorobjev, “Vertebrate primary cilia: a sensory part of centrosomal complex in tissue cells, but a ‘sleeping beauty’ in cultured cells?” Cell Biology International, vol. 28, no. 2, pp. 139–150, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. O. V. Plotnikova, E. A. Golemis, and E. N. Pugacheva, “Cell cycle-dependent ciliogenesis and cancer,” Cancer Research, vol. 68, no. 7, pp. 2058–2061, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. E. S. Seeley and M. V. Nachury, “The perennial organelle: assembly and disassembly of the primary cilium,” Journal of Cell Science, vol. 123, no. 4, pp. 511–518, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Seo, L. M. Baye, N. P. Schulz et al., “BBS6, BBS10, and BBS12 form a complex with CCT/TRiC family chaperonins and mediate BBSome assembly,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 4, pp. 1488–1493, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. L. M. Grimm and B. A. Osborne, “The role of the proteasome in apoptosis,” in Proteasomes: The World of Regulatory Proteolysis, W. Hilt and D. M. Wolf, Eds., pp. 315–331, Landes Bioscience, Georgetown, Tex, USA, 2000. View at Google Scholar
  42. C. Wójcik, “Regulation of apoptosis by the ubiquitin and proteasome pathway,” Journal of Cellular and Molecular Medicine, vol. 6, no. 1, pp. 25–48, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Braun, G. Carvalho, A. Coquelle et al., “NF-κB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome,” Blood, vol. 107, no. 3, pp. 1156–1165, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. S. P. Dawson, J. E. Arnold, N. J. Mayer et al., “Developmental changes of the 26 S proteasome in abdominal intersegmental muscles of Manduca sexta during programmed cell death,” The Journal of Biological Chemistry, vol. 270, no. 4, pp. 1850–1858, 1995. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Takayanagi, S. Dawson, S. E. Reynolds, and R. J. Mayer, “Specific developmental changes in the regulatory subunits of the 26 S proteasome in intersegmental muscles preceding eclosion in Manduca sexta,” Biochemical and Biophysical Research Communications, vol. 228, no. 2, pp. 517–523, 1996. View at Publisher · View at Google Scholar · View at Scopus
  46. G. N. DeMartino and T. G. Gillette, “Proteasomes: machines for all reasons,” Cell, vol. 129, no. 4, pp. 659–662, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Flandrin-Gresta, F. Solly, C. M. Aanei et al., “Heat shock protein 90 is overexpressed in high-risk myelodysplastic syndromes and associated with higher expression and activation of focal adhesion kinase,” Oncotarget, vol. 3, no. 10, pp. 1158–1168, 2012. View at Google Scholar · View at Scopus
  48. E. M. Creagh, D. Sheehan, and T. G. Cotter, “Heat shock proteins—modulators of apoptosis in tumour cells,” Leukemia, vol. 14, no. 7, pp. 1161–1173, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Y. Sherman and A. L. Goldberg, “Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases,” Neuron, vol. 29, no. 1, pp. 15–32, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. R. R. Kopito, “Aggresomes, inclusion bodies and protein aggregation,” Trends in Cell Biology, vol. 10, no. 12, pp. 524–530, 2000. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Lanneau, M. Brunet, E. Frisan, E. Solary, M. Fontenay, and C. Garrido, “Heat shock proteins: essential proteins for apoptosis regulation,” Journal of Cellular and Molecular Medicine, vol. 12, no. 3, pp. 743–761, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. A. R. Stankiewicz, G. Lachapelle, C. P. Foo, S. M. Radicioni, and D. D. Mosser, “Hsp70 inhibits heat-induced apoptosis upstream of mitochondria by preventing Bax translocation,” The Journal of Biological Chemistry, vol. 280, no. 46, pp. 38729–38739, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. H. M. Beere, B. B. Wolf, K. Cain et al., “Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome,” Nature Cell Biology, vol. 2, no. 8, pp. 469–475, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Takayama, J. C. Reed, and S. Homma, “Heat-shock proteins as regulators of apoptosis,” Oncogene, vol. 22, no. 56, pp. 9041–9047, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Kamada, A. So, M. Muramaki, P. Rocchi, E. Beraldi, and M. Gleave, “Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells,” Molecular Cancer Therapeutics, vol. 6, no. 1, pp. 299–308, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. W. K. Kim, H. J. Cho, S. I. Ryu et al., “Comparative proteomic analysis of peripheral blood mononuclear cells from atopic dermatitis patients and healthy donors,” Biochemistry and Molecular Biology Reports, vol. 41, no. 8, pp. 597–607, 2008. View at Google Scholar
  57. Z. H. Xue, C. Feng, W. L. Liu, and S. M. Tan, “A role of kindlin-3 in integrin αMβ2 outside-in signaling and the Syk-Vav1-Rac1/Cdc42 signaling axis,” PLoS ONE, vol. 8, Article ID e56911, 2013. View at Google Scholar
  58. D. R. Critchley, “Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion,” Biochemical Society Transactions, vol. 32, part 5, pp. 831–836, 2004. View at Google Scholar
  59. G. Nardo, S. Pozzi, S. Mantovani et al., “Nitroproteomics of peripheral blood mononuclear cells from patients and a rat model of ALS,” Antioxidants and Redox Signaling, vol. 11, no. 7, pp. 1559–1567, 2009. View at Google Scholar
  60. C. A. Schneider, W. S. Rasband, and K. W. Eliceiri, “NIH Image to ImageJ: 25 years of image analysis,” Nature Methods, vol. 9, no. 7, pp. 671–675, 2012. View at Google Scholar
  61. S. Ussar, H. V. Wang, S. Linder, R. Fässler, and M. Moser, “The Kindlins: subcellular localization and expression during murine development,” Experimental Cell Research, vol. 312, pp. 3142–3151, 2006. View at Google Scholar
  62. M. Moser, M. Bauer, S. Schmid et al., “Kindlin-3 is required for β2 integrin-mediated leukocyte adhesion to endothelial cells,” Nature Medicine, vol. 15, pp. 300–305, 2009. View at Google Scholar
  63. V. L. Morrison, M. MacPherson, T. Savinko, H. S. Lek, A. Prscott, and S. C. Fagerholm, “The β2 integrin-kindlin-3 interaction is essential for T-cell homing but dispensable for T-cell activation in vivo,” Blood, vol. 122, no. 8, pp. 1428–1436, 2013. View at Google Scholar
  64. S. Linder and P. Kopp, “Podosomes at a glance,” Journal of Cell Science, vol. 118, no. 10, pp. 2079–2082, 2005. View at Google Scholar